“Results of this case-control study suggest that even for maximum univariate biological differences, deviations between patients with MDD and healthy controls were remarkably small," experts shared in JAMA Psychiatry.

When these malfunctions occur, the FDA explained, it leads to an increased risk of additional interventions.

The new study, based on data from nearly 3,000 patients, compared DOACs such as rivaroxaban, apixaban and edoxaban with single and dual antiplatelet therapy. 

A new analysis offers a detailed comparison of soft-tissue lymphomas and soft-tissue tumors based on imaging characteristics from MRI scans—an area of study that has not yet been rigorously explored, the authors of the paper indicated.

These findings, researchers wrote, suggest that artificial sweeteners "should not be considered a healthy and safe alternative to sugar."

When combined with artificial intelligence-based noise reduction techniques, new photon-counting CT technology can increase the detection of bone disease while also decreasing radiation exposure. 

The company can now update its labeling instructions for the device to include a new 45-day dual anti-platelet therapy treatment option when treating non-valvular atrial fibrillation. 

While the number of possible mutations of the SARS-CoV-2 spike protein would be overwhelming for humans to analyze, machine learning may be able to offer critical insights for next-generation vaccines and antibody treatments.